INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis. Stojanovic I, Vojinovic S, Ljubisavljevic S, Pavlovic R, Basic J, Pavlovic D, Ilic A, Cvetkovic T, Stukalov M J Neurol Sci. 2012 Dec 15; 323(1-2):187-92. Epub 2012 Sep 28. PMID: 23026532. Abstract CommentRecommendBookmarkWatch